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Transcranial Direct Current Stimulation (tDCS) of the brain has been shown to have profound 
effects on many physiological and psychological processes, including effects on the autonomic 
nervous system and fatigue.  PURPOSE: The purpose of this study was to investigate the effects 
tDCS on parasympathetic and sympathetic nervous system modulation and their influence on a 
maximum effort fatiguing exercise protocol.  METHODS: Twenty recreationally active subjects 
(10 male; 10 female) volunteered to participate in this study.  Each individual visited the lab on 
four occasions.  The first visit was a familiarization visit.  Visits two through four consisted of a 
sham treatment, an anodal parasympathetic stimulation treatment, and an anodal sympathetic 
stimulation treatment, in random order.  The subjects sat in a dark, quiet environment for 30-min 
while receiving the appropriate stimulation.  The anode was placed on the T3 area, equidistant 
between the ear and the CZ point, while the cathode was placed on the contralateral side of the 
skull, just supraorbital.  Following stimulation, the subject completed 50 maximum intensity 
isokinetic (Biodex medical Systems, Inc., Shirley, New York) leg extensions at an angular 
velocity of 180°s-1, followed my passive flexion.  Autonomic modulation was quantified using 
time and frequency domain indices of heart rate variability.  The data were analyzed using 1x3 
repeated measures ANOVAs.  RESULTS: For the heart rate variability data there were no 
significant effects for high frequency power (F1.8,33.2 = 0.80, p = 0.44, Eta
2 = 0.04), low frequency 
power (F1.9,35.4 = 0.98, p = 0.38, Eta
2 = 0.05), inter-beat interval (F1.8,35.0 = 0.58, p = 0.55, Eta
2 = 
0.03), root mean square of successive differences (F2.0,38.0 = 1.32, p = 0.28, Eta
2 = 0.07), variance 
(F2.0,38.0 = 1.69, p = 0.20, Eta
2 = 0.08), or SD-1 (F2.0,38.0 = 1.32, p = 0.28, Eta
2 = 0.07).  Likewise, 
there was no significant effect of tDCS on mean torque (F2.0,37.5 = 0.73, p = 0.49, Eta
2 = 0.04) or 
peak torque (F2.0,38.0 = 0.22, p = 0.80, Eta
2 = 0.01).  CONCLUSION: In contrast to previously 
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published studies, the results of this study showed no effects of tDCS on cardiovascular 
autonomic modulation or fatigue during high intensity exercise.  Discrepancies between these 
results and other studies may be due to differences in stimulation protocol, brain area of 
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Transcranial Direct Current Stimulation is a non-invasive form of brain stimulation in which 
neurological excitation (38) in the cell membrane resting potential and changes in firing rate (30, 45) 
occur as a result of an electrical current from two electrodes placed on the scalp (31).  These two 
electrodes, cathode and anode, allow for two separate types of stimulation, which have been shown to 
yield opposite results.  Anodal stimulation causes depolarization and increases in excitement, while 
cathodal stimulation causes hyperpolarization and a decrease in excitement (3, 32).  These changes in 
excitement are not great enough to cause direct firing, but rather manipulate the potential nearer or 
further from threshold (12).  Due to the local effects of tDCS, moving either the anode or cathode to a 
different location can stimulate a different portion of the brain, under the electrode.  Dependent upon 
placement of these electrodes, there is some lateral stimulation that occurs in tissues interconnected to 
the area directly below the electrode (8, 58).  Although not completely understood, the mechanism of 
action for tDCS has been shown to elicit synaptic and non-synaptic changes to both cortical and sub-
cortical structures (46).  Additionally, tDCS has been shown to activate pyramidal cells and interneurons 
which interact via glutaminergic (AMPA) and GABAergic (GABAAr) receptors within the initial minute of 
stimulation which shows an immediate communication between stimulated and nearby tissue (30).  
Another adaptation that could facilitate neuronal changes is an increase in Cerebral Blood Flow (CBF) 
with anodal stimulation and decreases in CBF with cathodal stimulation (21, 24, 58).  Because of the 
neuromodulatory effect, plasticity changes, and increased CBF incurred through tDCS (6, 7), this method 
has been used to decrease the effects of neurological (17) or psychological disorders (2) as well as 
delaying the onset of fatigue (42).  Effects of tDCS are dependent upon frequency and time of 
stimulation as well as intensity of current (3, 53). 
 
Taking partial responsibility for the changes in excitability and plasticity are changes in 
membrane proteins and altered ion concentrations across the membrane flowing from anode to 
cathode (Figure 1) (57).  Been et al. showed that Na+ and Ca2+ blockers prevented both long and short 
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term effects of tDCS (4)  which would support the hypothesis that ion channels play an integral part in 
the response to tDCS.  pH changes have also been a proposed mechanism through which tDCS 
modulates brain activity, specifically causing changes in the levels of N-methyl-D-aspartic acid (NMDA) 
(26, 50).  Similar to ion changes, Been et al. found that NMDA blockers eliminate changes elicited by 
tDCS, however these only blocked the long term effects, leaving short term effects unaltered (4).  Glx 
(Glutamine + Glutamate) and NAA (N-acetyl aspartate) were also both found to increase, but only on the 
stimulated hemisphere (11).  Of the known mechanisms that act in response to tDCS, ion shifts appear 
to be largely controlled by the ionotropic AMPA, GABAA, and NMDA receptors which are responsible for 
changes in membrane potential, excitation, and plasticity, while molecular changes in glutamate (Glu), 
glutamine (Gln), and NAA could play an integral role in altering the concentrations of membrane 
proteins (21).   
The manipulation of membrane potential elicited by the direct current from tDCS would thus 
affect each of the aforementioned signaling molecules.  For example, cathodal stimulation of select 
portions of the brain could lead to inreased Glu necessary for NMDA receptor (NMDAr) activation.  
While NMDAr activation via Glu is necessary for many brain functions, over-activation of NMDA 
receptors can have CNS injury effects like hypoxia-ischemia, trauma, and status epilepticus (10, 33, 43).  
Similarly, hyper-stimulation of AMPA and Kainic Acid (KA) receptors can have neurodegenerative effects 
in diseases such as amyotrophic lateral sclerosis (ALS) (22, 33, 47).  Manipulating this pathway in the 
opposite direction would include the use of anodal tDCS as excitatory to the membrane potential, 
requiring lower levels of glutamate to activate under-excited NMDA receptors.  NMDA hypo-function 
has been linked to abnormal memory function, as well as psychiatric disorders such as Alzheimer’s 
Disease and psychosis (33). 
 
Figure 1. Mechanisms of action of tDCS.  Ionic shifts and transmembrane protein changes result in 
altered cortical excitability (57). 
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 Neuromuscular fatigue has many similar definitions; as defined by Millet (27), fatigue occurs 
when there is a decrease in the maximal voluntary force or power of a single muscle or muscle group 
whether or not the task can be sustained.  Enoka and Stuart defined fatigue as, “ a general concept 
intended to denote an acute impairment of performance that includes both an increase in the perceived 
effort necessary to exert a desired force and an eventual inability to produce this force” (16).  “Fatigue is 
a multi-factorial physiologic process involving continual functional adjustments in the nervous system 
and the muscle throughout the contractions” (56).  It has been previously demonstrated that anodal 
tDCS on the parasympathetic nervous system increases the power output throughout a submaximal 
exercise test (42). 
 
 Transcranial direct current stimulation has numerous upsides over pharmaceutical treatments 
for neurological and psychological diseases and disorders, such as few adverse effects, high efficacy, and 
economical practicality in clinical, research, or individual therapy settings (55).  Another reason to 
further investigate the effects of tDCS is to gain understanding about central and peripheral fatigue and 
the individual mechanisms of each that combine to decrease optimal functionality of a muscle or muscle 
group.  This is an appropriate area of study not only for determining ways to improve physical 
performance of athletes, but how to maximize the aerobic and anaerobic abilities of diseased, disabled, 
and aging individuals (49).   
 
Statement of the Problem 
  
 The purpose of this study was to investigate the effects of anodal tDCS of both the sympathetic 
and parasympathetic nervous system, compared to a sham treatment, looking at the force output 
during a maximal exercise test.  There are currently studies searching for answers regarding tDCS and 
submaximal exercise (29, 51, 56) as well as maximal exercise and the effect of tDCS on the autonomic 
nervous system (42).  However, there appear to be no studies published comparing sympathetic 
stimulation to parasympathetic stimulation prior to maximal exercise.  Also of interest was the effect of 




Hypothesis and Specific Aims 
 
Hypothesis 
 The hypothesis of this study stated that there would be significant increases in HRV during the 
parasympathetic stimulation but that the decreased fatigue would occur during the sympathetic 
stimulation visit due to the short duration and high intensity of the Thorstensson Fatigue Protocol. 
 
Specific Aim #1 
 To determine if there was a significant difference in fatigue following sympathetic stimulation, 
parasympathetic stimulation, or a sham treatment. 
 
Specific Aim #2 
 To determine if there was a significant difference in heart rate variability during stimulation of 
the sympathetic nervous system, the parasympathetic nervous system, or a sham treatment. 
 
Specific Aim #3 
 To determine if there was a significant difference in where fatigue during maximal exercise 









Explanation of Terms 
 
 Transcranial Direct Current Stimulation (tDCS) – A small dose of electricity (≤2.0mA) was sent 
into the subject’s insular cortex.  This electricity causes changes in excitability to occur in the local tissue 
under the electrode (23).  Although tDCS is not a strong enough current to cause an action potential, it 
does cause a slight depolarization, keeping up a level of excitability for up to an hour following 
stimulation. 
 
 Heart Rate Variability (HRV) – The subject had three electrocardiogram (ECG) electrodes 
attached, one immediately inferior to the right clavicle, one located on the V5 location, and the 
reference electrode on the spinous process of the C3 vertebrae.  These electrodes read each heart beat 
and a customized software was used, allowing the time between beats to be calculated in order for the 
HRV to show the effects of tDCS on the autonomic nervous system. 
 
 Surface Electromyography (EMG) – Bipolar EMG electrodes were used to record the action 
potentials as they move down the length of the muscle fibers of the rectus femoris, vastus lateralis, and 
vastus medialis.   
 
 Maximum Voluntary Contraction (MVC) – The subject kicked out against an isometric lever arm 
and a connected load cell reads the force produced.  This test was run before and after the TFP as a way 
to determine the source of muscle fatigue. 
 
 Evoked Twitch (ET) – In order to determine the type of fatigue that was occurring over the 
course of the Thorstensson Fatigue Protocol (central or peripheral), a bipolar electrode was utilized to 
straddle the subject’s femoral nerve.  Once the nerve was located, small doses of electricity were sent 





 Thorstensson Fatigue Protocol (TFP) – A protocol directed to fatigue the leg extensor muscle 
group, requiring 50 maximum force kicks from 90° to full extension (0°), while attached to an isokinetic 
dynamometer.  This protocol limitedthe subject to a fixed angular velocity of 180°s-1, taking 0.5s for the 






1. Subjects honestly and accurately reported all information on the health history 
questionnaire. 
2. Maximal effort was given during each MVC and every TFP repetition. 



















1  Transcranial Direct Current Stimulation 
 
Transcranial Direct Current Stimulation (tDCS), also known as brain polarization, is a 
method of neural modulation that has been around for centuries (1).  tDCS has been shown to 
improve motor learning, motor performance, treat depression, Alzheimers, Parkinsons, chronic 
pain, stroke, drug addiction, and appetite regulation as well as numerous other neurologic and 
psychiatric conditions (9).  It has also been shown that tDCS prior to practicing a motor task can 
improve speed, accuracy, motor learning and recovery during and after that task (56).  Due to 
these marked improvements, Transcranial Direct Current Stimulation is becoming an often-used 
tool in both the clinical world, for rehabilitation and therapy, as well as the research world. 
 
Most research to date uses tDCS as a treatment lasting 10-30 minutes at a current 
ranging from 1.5-2.0mA.  Recent literature has proposed that possible acute, repeated exposure 
to tDCS could also bring about some of the positive effects.  One such study (5) compared thirty 
30-s rounds of tDCS with 5-s rest between each to an oscillating current performed for the same 
protocol.  This study showed a similar increase when using short bouts of tDCS compared with 
the slow oscillating current.  Bergmann’s study further lends to the idea that increasing 
excitability in the brain is more a product of modulation of membrane potential, rather than 
causing actual action potentials(56).   
 
There are numerous upsides to tDCS compared to many pharmacological interventions 
that produce the same effect.  Williams showed that due to localized excitability changes under 
the electrodes only, tDCS is a way to modulate certain portions of the neuromuscular system 
without affecting the entire system (56).  Another benefit is that there is no lingering effect.  
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Once the polarization returns to normal, no other effects can be noticed.  Although it is 
somewhat dependent on intensity, density, and duration of the stimulus, corticomotor 
excitability tends to persist for roughly 1 hour after treatment (29, 35-37). 
 
2  Heart Rate Variability 
 
The autonomic nervous system (ANS) is a key component for exercise performance, 
fatigue development in certain diseases, and life itself.  Heart Rate Variability (HRV) is a key 
marker for how the ANS is functioning.  Heart Rate tends to be controlled in large part by the 
temporal cortex.  The temporal cortex is involved in motor control, and the left side of the brain 
is responsible for happy, enjoyable sensation, while the right side tends to be responsible for 
less pleasant sensations such as pain and heat (42).   
 
Through stimulation of the insular cortex, anodal stimulation of the right side of the 
brain has shown increased sympathetic cardiovascular responses, while anodal stimulation of 
the left side of the brain has shown reduced parasympathetic cardiovascular effects(42).   
 
Montenegro recently demonstrated that tDCS above the temporal cortex causes 
increases in parasympathetic activity at rest in an athletic population (31).  Okano expanded this 
hypothesis to a dynamic exercise test.  The results showed that with a 20-minute treatment of 
anodal transcranial direct current stimulation prior to a dynamic exercise test, parasympathetic 
activity was increased and exercise performance was improved by ~4% (42).  The conclusions 
that can be drawn from this are that during an aerobic fitness test, parasympathetic stimulation 
leads to higher vagal modulation, which yields longer parasympathetic withdrawal, leading to a 






3  Fatigue 
 
Fatigue is most often associated with alterations from homeostatic conditions (40)occurring 
anywhere between the brain and muscle fibers (54).  There are numerous points from which this 
fatigue can occur.  Starting at the brain, cerebral hypoxia has been proposed as a mechanism of 
fatigue (20), as have motivation, environment, tiredness, and lethargy (54).  Fuglevand et al. has 
suggested that inadequate cerebral excitation could be a primary cause of fatigue(18).  Moving 
down to the level of muscle, Weir et al. suggests that intramuscular levels of lactic acid and H+, lack 
of Oxygen availability, Pi accumulation, and extracellular K+ accumulation, among other peripheral 
factors can play a role in the reduction of force output by the muscles (54). 
 
1. Neuromuscular Fatigue 
 
There are many different definitions of neuromuscular fatigue.  Millet defines it as 
“….exercise related decrease in maximal voluntary force or power of a single muscle or 
muscle group whether or not the task can be sustained” (19, 27).  Gandevia et al. takes 
fatigue a step further by discussing the progressive nature, “….the maximal force 
generating capacity of muscles starts to deline once exercise commences so that fatigue 
realy begins almost at the onset of exercise and develops progressively before the 
muscles fail to perform the required task” (19).  Enoka and Stuart describe it as, “ a 
general concept intended to denote an acute impairment of performance that includes 
both an increase in the perceived effort necessary to exert a desired force and an 
eventual inability to produce this force” (16).  Fatigue can also simply be described as a 
decrease in EMG amplitude during either prolonged or high intensity exercise.  One 
thing that most definitions have in common is the lack of a single mechanism.   
 
These individual mechanisms involve central fatigue and peripheral fatigue, as well as 
central fatigue and peripheral fatigue working in conjunction (25).  Neuromuscular 
fatigue can occur anywhere from the brain to the skeletal muscle.  Although they often 
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accompany one another, central and peripheral fatigues are well recognized as mutually 
dependent (27).  Fatigue appears to refer to any number of acute occurances leading to 
decreased performance, rather than any one mechanism.  Enoka et al. said, “Fatigue is 
not the consequence of a single omnipresent mechanism, but rather that it can be 
induced by a variety of mechanisms” (16).  Task dependency, as this is commonly known 
would state that the mechanism responsible for fatigue is a product of the type of task 
being completed.  This involves such variables as intensity, type, muscle groups, 
environment, training status, etc. (54). 
 
Neuromuscular fatigue affects people with diseases and disabilities, both 
physiological and psychological, as well as aging individuals, and athletes.  For these 
populations and many more, understanding the underlying mechanisms of fatigue at 
every level is an important task.  A further understanding could lead to advances in 
prevention and rehabilitation, as well as performance.  Fatigue is a multi-factorial 
physiologic process involving continual functional adjustments in the nervous system 
and the muscle throughout the contraction (56).   
 
2.1 Peripheral Fatigue 
 
A local fatigue effect, peripheral fatigue is often considered to be any fatigue 
occurring outside of the central nervous system.  Fatigue can occur in the central 
nervous system, making its way down to the periphery through the nervous system, or 
it can root more strictly in the periphery.  Peripheral fatigue is dependent on both the 
type of stimulation and the time allowed for recovery following stimulation, and even a 







2.2 Central Fatigue 
 
Central fatigue involves supraspinal and spinal fatigue (13).  It occurs when there 
is a progressive failure of the nervous system to drive muscle during exercise (13).  
Twitch interpolation is the main method of exploration into central fatigue (27, 29).  
 
The Central Governor Model (CGM) has been around for sometime, which 
proposes that the central nervous system is wholly responsible for fatigue in the 
periphery (39).  The CGM proposes that fatigue is less a physical event than it is a feeling 
or emotion, similar to Rating of Perceived Exertion (RPE) (41), and that power output 
during exercise, and the decreases seen, are due to signaling from the subconscious 
brain, rather than the level of muscle itself.  This idea stems from the fact that the 
central nervous system would ultimately be protecting the periphery from working so 
hard as to cause a catastrophic failure (40, 54).   
 
2.3 tDCS & Fatigue 
 
Transcranial Direct Current Stimulation works to increase excitability in the area directly 
beneath the anodal electrode (51).  As this excitability begins in the brain, it can then move 
down toward the spinal cord and periphery.  Delaying fatigue through tDCS to supraspinal 
motor cortex could help compensate for decreases in spinal excitability as task duration 
continues (56).  Due to the cortical excitation elicited on numerous brain structures by anodal 
stimulation (4, 28), the idea of stimulation of the insular cortex could work to alter autonomic 
nervous system function. 
 
As exposed tissue becomes polarized, excitability is increased via anodal stimulation or 
decreased via cathodal stimulation (42).  These neuromodulatory changes begin in the human 
insular cortex and the excitation can spread from there.  Cogiamanian et al. 2007 completed a 
study comparing anodal stimulation to cathodal stimulation and sham.  The results showed that 
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anodal stimulation to the cortical motor area induced increasing endurance time for sustained 
submaximal isometric contractions and also significantly attenuated the decline in endurance 
time from baseline to postconditioning when compared to cathodal stimulation and the sham 
treatment (13).  Cogiamanian et al. 2007 theorizes that this prolonged endurance time was due 
to increased cortical excitation, resulting in “increased supraspinal drive by inducing a prolonged 
facilitation of corticospinal neurons.”  In 2013 Williams et al showed that anodal stimulation 
caused a 6% decrease in fatigue compared with sham while increasing the time to failure by > 
30%.  There was also a lowered rating of percieved exertion (RPE) during the first half of the task 
allowing a 38% increase in time at high effort.  When completing a maximum exertion cycling 
protocol (15W + 25W/min until unable to keep 80rpm cadence for >5s) following 20 minutes of 
2.00mA anodal transcranial stimulation (parasympathetic), subjects saw significant increases in 
HRV, peak power output, and time to exhaustion compared to a sham treatment (42). 
 
It has been shown in several studies to date that excitation of the parasympathetic 
nervous system decreases the fatigue during a submaximal test by either increasing the force 
produced over a set time (42) or increasing the time to exhaustion (56).   The further question 
that needs to be asked is how will sympathetic stimulation effect fatigue, and will it decrease 
fatigue over a maximal intensity, short duration exercise test? 
 
3 Thorstensson Protocol 
 
As a means to look at fatigue differences in fiber type of skeletal muscle, Thorstensson 
and Karlson developed a protocol involving 50 maximal contractions of the knee extensors from 
90° to full extension (0°).  These extensions take place on an isokinetic dynamometer at set 
velocity of 180°s-1, with the entire 50 contractions occurring over the span of one minute (52). 
To assure constant resistance to each contraction the isokinetic dynamometer controls the 
opposition to each kick.  Although the original study was designed to look at fatigue differences 




Peak torque will be recorded for each contraction through the protocol and the average 
of the highest three values from the first ten repetitions (Initial Peak Force) will be compared to 
the average of the highest three values from the final ten repetitions (Final Peak Force) to find 




4 Evoked Twitch 
 
Evoked twitch is a method of determining the maximal amount of  
Activation an individual can achieve involuntarily.  In order to determine where fatigue is 
occurring, the evoked twitch sends a small electrical stimulus through the femoral nerve, similar 
to how the central nervous system would send an electrical stimulus.  Applied through a 
superficial bipolar electrode straddling the femoral nerve as it crosses the inguinal crease, 
Evoked Twitch performed before and after a fatiguing protocol allows for a view as to whether 
the fatigue is occurring in the central nervous system or closer to the neuromuscular junction. 
 
Millet points out that it is imperative to retest the Evoked Twitch immediately 
following the end of the Fatigue Protocol because short periods of muscle recovery can 
have immense effects on the power output from those fatigued muscles (27).  Thus it 
becomes important that the twitch is administered within only a few seconds following 





















 Ten male and ten female subjects volunteered their participation in this study.  Prior to 
participation they were screened for current or past neuromuscular or musculoskeletal injuries as well 
as any metal implants above the neck, besides common orthotic braces.  The study was submitted and 
approved by The University of Kansas Institutional Review Board to assure protection of all human 
subjects.  Each subject was required to sign an informed consent document as well as complete a health 
history questionnaire. 
 
3.2 Research Design 
 The study consisted of four days on which the subjects were asked to visit.  The first visit 
consisted of familiarization with the equipment and procedures of the study.  Visits two through four 
each consisted of one randomized treatment, either parasympathetic stimulation, sympathetic 
stimulation, or a sham treatment (Fig 3.2).  Every visit began with the electrode site preparation, 
followed by a 30-minute tDCS treatment or sham treatment.  On the visits where a 3-minute treatment 
was administered the subjects had the anode placed on the right side (sympathetic stimulation) or the 
left side (parasympathetic stimulation).  The anode was attached 40% of the way from the most superior 
point on the skull.  The cathode was placed on the contralateral side of the head, just supra orbital (42).  
There was a 30-second ramp up to constant current of 2.00mA and a 30-second ramp down at the 
beginning and end of each treatment.  During the sham, the subjects received a 30-second treatment so 
that the initial tingling sensation was present and the subject remained blinded to the treatment.  The 







Transcranial Stimulation (Treatment or Sham) 
(Heart Rate Variability Collected) 
 
Evoked Twitch  
(EMG & Torque Collected) 
 
Maximum Voluntary Contraction 
(EMG & Torque Collected) 
 
Thorstensson Fatigue Protocol 
(EMG & Torque Collected) 
 
Evoked Twitch 
(EMG & Torque Collected) 
 
Maximum Voluntary Contraction 
(EMG & Torque Collected) 
 
 
3.2.1 Heart Rate Variability 
At the start of the tDCS treatment or sham, heart rate variability was measured through the end 
of the 30-minute treatment.  The room was kept dark and quiet, and the subject was asked not to speak 
unless necessary.  There was a trained member of the research team present at all times, to assure that 
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the subject remained awake.  ECG data was collected with a UFI Model 2122i Bioamplifier (UFI 
Instruments, Morrow Bay, CA) which fed into a four-channel NI-9215 analog input module (National 
Instruments Corporation, Austin, TX). 
 
HRV was assessed using five specific variables.  To assess the variability between beats, Inter-
Beat Interval (IBI) was used as a measure of time between R-waves and Root Mean Square of the 
Successive Differences (RMSSD) was used to compare adjacent R-R intervals.  Low Frequency Power (LF) 
defined as 0.04-0.15Hz and High Frequency Power (HF) defined as 0.15-0.40Hz were used to determine 
autonomic nervous system control over HRV.  While LF is influenced by both sympathetic and 
parasympathetic nervous system activity, HF includes only the exertion of the parasympathetic nervous 
system. Finally, SD-1 was utilized, looking at the standard deviation perpendicular to the line of identity 
in a Poincare Plot. 
 
3.2.2 Evoked Twitch (ET) 
 Following tDCS, the subject was moved to the isokinetic dynamometer, where they were safely 
strapped in using the restraining straps over the contralateral thigh, pelvis, and crossing over each 
shoulder across the trunk.  Subjects remained seated on the isokinetic dynamometer and a bipolar 
stimulating electrode straddled the femoral nerve as it crosses the inguinal crease.  The researcher 
asked the subject to sit passively as the bipolar stimulating electrode delivered an electrical current 
causing the leg extensor muscle group to contract.  Prior to the TFP a maximum ET was found.  The 
subject’s femoral nerve was located by finding the pulse in the inguinal crease.  The cathode and anode 
of the electrode (Digitimer DS7AH, Hertsfordshire, UK) straddled this point, thus straddling the femoral 
nerve.  This stimulus, beginning at a nearly imperceptible 30mA was increased by 5mA and twitches 
were administered at these 5mA increments until maximal amplitude was achieved, as recorded during 
the procedure.  Once this maximal amplitude was reached, the Digitimer was increased by ~20% and a 
series of three twitches were evoked, in order to assure that it was a true maximum (48).  Immediately 
following the TFP another series of three twitches was evoked, beginning at the final amplitude used 
before the TFP and increased until maximal amplitude was again reached, to see if the fatigue occurring 




3.2.3 Maximal Isometric Voluntary Contraction (MVC) 
After a maximal evoked twitch amplitude was found, subjects remained seated with the right 
leg flexed at 90°, subjects were asked to kick, giving maximal effort, against an isometric load cell.  Three 
MVC’s were administered immediately following tDCS and prior to the TFP and three more came 
immediately after the TFP.  Strong verbal encouragement was provided to assist the subject in achieving 
a true maximal contraction. 
 
3.2.4 Thorstensson Fatigue Protocol (TFP) 
 The fatigue protocol had subjects remain seated and strapped into the Biodex System 3 Pro 
Isokinetic Dynamometer (Biodex Medical Systems Inc, Shirley, NY).  The machine was then switched 
from isometric mode into isokinetic mode, and the lever arm was set at 180°s-1.  Subjects completed 50 
maximum effort isokinetic leg extensions from 90° to full extension (0°).  Each concentric phase was 
active, lasting 0.5sec while the eccentric phase was passive until the leg has returned to 90°, lasting 





Peak Force was defined for each of the 50 repetitions as the highest point on the curve 
attained from the torque transducer attached to the isokinetic dynamometer.  Using peak force, 
area under the curve was calculated for the entire fifty repetition protocol.  Initial Peak Force is 
defined as the average of the highest three Peak Force values from the first ten repetitions and the 
















  Pre-amplified, bipolar surface EMG electrodes with fixed center-to-center inter-electrode 
distance of 20mm, input impedance of 100MΩ, and common mode rejection ratio of 95dB (nominal) 
were taped over the VL, RF, and VM muscles of the right leg.  A single reference electrode was 
placed on the bony process of the patella.  The skin under all electrodes was shaved and cleaned 
with isopropyl alcohol before the electrodes were attached to reduce inter-electrode impedance 
and increase the signal-to-noise ratio.  
 
3.2.6 Signal Processing 
 All EMG (uV) and Torque (V) signals were analyzed using custom programs written for LabView 
2011 (National Instruments Corporation, Austin, TX)   
 
3.2.7 Statistical Analysis 
 All variables were calculated using custom LabView 2011 programs.  HRV and TFP variables were 
analyzed using 1x3 repeated measures ANOVA’s.  Evoked twitch and MVC variables were calculated 
using 2x3 (time x treatment) repeated measures ANOVA’s.  A Huynh-Feldt correction for sphericity was 
applied to all statistical models.  For EMG variables during the Thorstensson Fatigue Protocol confidence 















4.1 Heart Rate Variability 
 
Descriptive statistics for Heart Rate Variability (HRV) variables can be found in Table 1.  Spaghetti graphs 
of individual responses are seen in Figure 1.  The autonomic response to transcranial direct current 
stimulation showed no significant effect for treatment for High Frequency Power (F1.8,33.2 = 0.80, p = 0.44, 
Eta2 = 0.04), Low Frequency Power (F1.9,35.4 = 0.98, p = 0.38, Eta2 = 0.05), Inter-Beat Interval (F1.8,35.0 = 
0.58, p = 0.55, Eta2 = 0.03), RMSSD (F2.0,38.0 = 1.32, p = 0.28, Eta2 = 0.07), Variance (F2.0,38.0 = 1.69, p = 0.20, 
Eta2 = 0.08), or SD-1 (F2.0,38.0 = 1.32, p = 0.28, Eta2 = 0.07).  These results show that regardless of which 
side of the brain was stimulated, the autonomic nervous system was unaltered by this direct current 
transcranial stimulation protocol of the insular cortex. 
 
 
4.2 Evoked Twitch 
 
Descriptive statistics for all Evoked Twitch (ET) variables can be found on Table 2.  Individual responses 
are shown on spaghetti graphs in Figure 2.  ET Torque showed a significant main effect for time (F1.0,19.0 = 
26.21, p = 0.01, Eta2 = 0.58), but showed no significance in the main effect for condition (F1.9,36.1 = 0.61, p 
= 0.54, Eta2 = 0.03) or the condition by time interaction (F1.9,35.4 = 0.38, p = 0.67, Eta2 = 0.02).  Evoked 
Twitch Peak-to-Peak M-Wave Amplitude showed no significant main effect for either time (F1.0,19.0 = 0.07, 
p = 0.79, Eta2 = 0.00) or condition (F1.8,33.4 = 0.07, p = 0.92, Eta2 = 0.00), as well as no significant 
interaction for condition by time (F2.0,38.0 = 0.48, p = 0.63, Eta2 = 0.02).  These results showed that the 
torque exerted by subjects following an Evoked Twitch decreased from pre- to post-Thorstensson, 
showing that fatigue did occur but the level of fatigue did not differ based on whether sham, 
parasympathetic stimulation, or sympathetic stimulation was received.   
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4.3 Maximum Voluntary Contraction 
 
Maximum Voluntary Contraction (MVC) descriptive statistics can be found in Table 3.  Individual 
response spaghetti graphs for all MVC variables are found in Figures 3-5.  While MVC Torque showed a 
significant main effect for time (F1.0,19.0 = 19.09, p = 0.00, Eta2 = 0.50), MVC Torque did not have a 
significant main effect for condition (F2.0,38.0 = 0.14, p = 0.87, Eta2 = 0.01) or a significant interaction for 
condition by time (F1.8,34.6 = 0.84, p = 0.43, Eta2 = 0.04). There was also no significant main effect for MVC 
Median Power Frequency for time (F1.0,19.0 = 0.75, p = 0.40, Eta2 = 0.04), MVC Median Power Frequency 
for condition (F1.6,30.4 = 2.60, p = 0.10, Eta2 = 0.12), MVC RMS for time (F1.0,19.0 = 1.08, p = 0.31, Eta2 = 
0.05), MVC RMS for condition (F2.0,37.9 = 0.53, p = 0.59, Eta2 = 0.03), and no significant interaction looking 
at condition by time for MVC Median Power Frequency  (F1.7,31.5 = 0.14, p = 0.84, Eta2 = 0.01) or MVC 
RMS (F1.6,31.3 = 2.37, p = 0.12, Eta2 = 0.11).  This would demonstrate that the TFP appropriately fatigued 
the muscles, decreasing the MVC Torque from pre- to post-, but that there was no change in MPF or 
RMS and that the condition did not significantly alter any of the MVC variables. 
 
 
4.4 Thorstensson Fatigue Protocol 
 
Table 4 shows descriptive statistics from the TFP area under the curve data, and spaghetti graphs 
showing individual responses to the TFP are found in Figures 6 and 7. The TFP showed no significant 
main effect for TFP Power (F2.0,38.0 = 0.00, p = 1.00, Eta2 = 0.00), TFP Mean Torque (F2.0,37.5 = 0.73, p = 0.49, 
Eta2 = 0.04), TFP Peak Torque (F2.0,38.0 = 0.22, p = 0.80, Eta2 = 0.01), Fatigue Index Torque (F2.0,57.0 = 0.018, 
p = 0.98, Eta2 = 0.01), and Fatigue Index Power (F2.0,57.0 = 0.21, p = 0.81, Eta2 = 0.01), demonstrating that 
the stimulation condition had no effect on subjects’ performance during the TFP.  When looking at the 
EMG Amplitude over the course of the TFP, the VL slope (F(1.91,36.20) = 3.50, p = 0.04, Eta2 = 0.16) showed a 
significant main effect while the VL intercept (F(1.66,31.51) = 1.45, p = 0.25, Eta2 = 0.07)  showed no 
significance from beginning to end for the Vastus Lateralis.  Looking at the Rectus Femoris and Vastus 
Medialis there was no significance found for RF Slope (F(2.00,38.00) = 0.19, p = 0.83, Eta2 = 0.01), RF 
Intercept (F(2.00,38.00) = 0.25, p = 0.78, Eta2 = 0.01), VM Slope (F(1.80,34.10)= 0.37, p = 0.67, Eta2 = 0.02), or VM 
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Intercept (F(1.66,31.61) = 1.21, p = 0.31, Eta2 = 0.06).  Figure 8 demonstrates the changes between condition 
for all slopes and intercepts.  The slightly significant change in VL slope coupled with the lack of 
significance in any of the other slope and intercept values as well as the large individual variability in 
Figure 8 would lead to the conclusion that the slope and intercept values do not change based on 
condition. 
Table 5 shows the 95% Confidence Interval for differences about the mean for EMG Amplitude Slope 
and EMG Amplitude Intercept for all three of the muscles (VL (Vastus Lateralis), RF (Rectus Femoris), and 
VM (Vastus Medialis)).  Significance was found in the 95% Confidence Interval for VL Slope Sham 
condition, as well as the Sham, Parasympathetic, and Sympathetic conditions for each of the VL, RF, and 
VM.  The Confidence Interval shows that the range in which the VL Slope during Sham and the VL, RF, 






















The present study showed that there were no changes in HRV variables related to the 
autonomic nervous system when comparing the sham treatment to the parasympathetic and 
sympathetic treatments.  The only significant findings associated with the ET, MVC, and TFP were seen 
when comparing the ET Torque and MVC Torque by time.  This demonstrates that muscular fatigue was 
occurring during the TFP.  However, there was no significant change to any variables when compared by 
treatment and no interactions when looking at condition by time. 
Of particular interest in the current study was the insular cortex which is responsible for 
numerous functions in the human body including basic emotion, perception of pain, and autonomic 
nervous system control (34).  Since the idea of the current study relates to changes in the autonomic 
nervous system and effects of fatigue, rather than completing a motor task, the insular cortex was 
targeted, instead of the motor cortex, as is seen in a majority of tDCS studies (2, 3).  While the motor 
cortex is an appropriate target when looking to rehabilitate from a stroke, or Parkinson’s disease, 
changes in movement were not of interest in the current study.  Instead, changes in insular excitation 
would theoretically lead to effects on the entire body.  The idea was to see how autonomic nervous 
system stimulation affected fatigue of the periphery.   
To our knowledge, this was the first study looking at the effects of transcranial direct current 
stimulation on fatigue during a maximal anaerobic exercise test.  In a previous study, a link was shown 
between the modulatory effects of tDCS and prolonged maximal exercise.  Okano et al. showed that 
with anodal tDCS to the parasympathetic nervous system (anode on the left side) cyclists had a greater 
time to exhaustion, a decreased Rate of Perceived Exertion (RPE), and decreased heart rate at 
submaximal levels.  The decreased heart rate is hypothesized to have been in response to a increased 
parasympathetic modulation and possibly due to a decrease in sympathetic modulation that comes with 
exciting the left hemisphere of the insular cortex (42).  In the present study HRV data was collected 
during stimulation, prior to exercise.  Using this model, no changes in autonomic response were 
discovered when comparing all three conditions: sham, parasympathetic anodal stimulation, and 
sympathetic anodal stimulation. 
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 The lack of any significant effect on HRV via tDCS would  signify that the transcranial direct 
current stimulation had no effect on the autonomic nervous system while the subject was quietly seated 
in a dark, quiet environment.  As shown by Okano, the effect was present when HRV was collected 
during exercise (42).  This presents a need for further study to discern whether anodal stimulation to 
either the parasympathetic or sympathetic autonomic nervous system could result in a potential 
excitation of the insular cortex that manifests itself only when necessary (i.e. during exercise).  A 
comparative study to collect HRV data during stimulation and during exercise would help to answer this 
question. 
 There are a handful of possible reasons that the Okano paper saw significant changes from sham 
when using parasympathetic stimulation (42) while the current study did not.  One possibility could be 
the training status of the subjects.  While the present study looked at recreationally trained individuals, 
Okano et al. was using “national level road cyclists” (42).  Another deviance from the Okano study is the 
type of exercise.  In that study a maximal incremental exercise test was performed, whereas the current 
study was looking at a maximal anaerobic exercise test.  The type of exercise and the portions of the 
autonomic nervous system excited by each could have played a role in the significance or lack thereof 
that was incited via tDCS.  The size and placement of the anodal pad could have also caused an issue.  
The smallest recommended pad size is 5x5cm, but the anodal pad used, as included in the stimulation 
kit, was 6x8.5cm.  There is a chance that the large pad diluted the current sent out from the anode, 
sending weaker signals to a greater area of the brain.  Due to the small size of the insular cortex, a 
majority of these brain areas being stimulated may have been outside of the targeted insular cortex, and 
thus the excitation was either wasted, or possibly inhibitory to the hypothesized effect.  Thus, there are 
numerous possible reasons why the current study showed no significant changes while one past study 
(42) did show significance. 
 As understanding of the structures and specific functions of the brain become better 
understood, tDCS and its effects will also become more clear.  When anodal stimulation is conducted 
over the T3 area, it is affecting the insular cortex, but what effect is it having on neighboring areas of the 
brain?  Lang et al. found that even anodal stimulation over the T3 area resulted in structures throughout 
“the dorsal portion of the cerebral hemisphere” being excited and cathodal stimulation of the same area 
to act on other portions of the brain (24).  It appears that this is due to the difference in activation or 
inhibition at the site directly below the stimulation site, and how that increase or decrease in excitation 
leads to different signaling throughout the brain based on different cortico-cortical neural networks.  As 
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a whole, the brain depends on functional connectivity of neurons in many regions to for the processing 
of information (44).  The direct effects of tDCS will become much better understood as these excitable 
signaling pathways in the brain become more fully understood. 
Although the current study satisfied the null hypothesis for all autonomic variables, showed no 
change between conditions for the TFP, and showed no condition by time interaction on EMG variables 
for Maximum Voluntary Contraction and Evoked Twitch, there was a significant main effect for time in 
both MVC Torque and ET Torque.  As seen through this significant decrease in Torque values for both 
the MVC and ET, it is clear that fatigue does occur during the TFP.  The fifty-kick, maximal effort protocol 
caused drastic decreases in the torque produced from pre- to post-, but did not show differences based 
on condition.  Despite the lack of changes in autonomic response and the lack of significant differences 
between treatments, the TFP was validated as a highly effective method for fatiguing the vastus 
lateralis.   
Also of interest is the EMG response during the Thorstensson Fatigue Protocol.  No significant 
changes were observed in the TFP Power or Torque variables, but a slight difference (p = 0.04) was seen 
in the EMG Slope of the vastus lateralis.  To further analyze this the slope values were looked at for the 
rectus femoris (p = 0.83) and vastus medialis (p = 0.67).  As neither showed significance, it was deemed 
that the change in VL EMG Slope was not meaningful, although it did demonstrate statistical 
significance.  There was no significance for the intercept in any of the three muscles.  This shows that 
there was not a significant change in the slope or intercept values for any of the three muscles when 
comparing the three conditions.  However, when looking at the 95% Confidence Interval the 
parasympathetic condition for VL Slope and VL Intercept showed to be significantly elevated above the 
sham with no significant change between sham and sympathetic or parasympathetic and sympathetic.  
There was no change between any of the conditions for the RF or VM.    
Although it was statistically significant, but not meaningful, the fact that the EMG Slope of the 
vastus lateralis was not equal to zero could suggest that there was a decrease in motor unit activation 
during the Thorstensson Fatigue Protocol.  This decrease in motor unit activation could indicate the 
occurrence of central fatigue.  Further studies are needed to investigate central fatigue, utilizing twitch 







The present study brings to light numerous other directions for further research in the area of 
transcranial direct current stimulation and its effects on peripheral function.  A link between the 
autonomic effects during stimulation and during exercise could show some significance as to how the 
timing of transcranial direct current stimulation affects autonomic performance.  On a similar note, 
when the tDCS is done in relation to exercise it could have effects on performance, for example, what 
would happen if the insular cortex was stimulated during an exercise test?  Also, does the type of 
exercise make a difference?  Okano et al. used an exercise test to exhaustion (42), which is not a 
completely anaerobic test, whereas the current study used a maximal exercise test lasting exactly one 
minute.  Based on the different mechanisms of fatigue, both central and peripheral, the fatigue seen 
during these two tests could be stemming from different mechanisms.  Does training age or training 
status alter the effects of tDCS?  Would an athlete be more or less apt to show changes in performance 
after undergoing tDCS?  The type of athlete, aerobic or anaerobic could also effect how stimulation 
alters their physiological response.  What would be the response to tDCS when performing a gait 
analysis, and could this change the gait during a more aerobic performance test?  When looking at the 
Okano study, could the reduction in RPE affect the form of an exerciser as they begin to fatigue, 
decreasing the chance of injury (42)?  Could transcranial stimulation affect the reflexes?  If so, there 
could be numerous possibilities as far as athletes, general population, physical therapy, and the 
prevention of frailty in aging adults.  Mordillo-Mateos et al. compared bilateral electrode placement to 
unilateral electrode placement (32), which presents the question of how the effects would differ 
following anodal stimulation with the cathode placed somewhere other than the contralateral 
supraorbital.  Also of interest could be hormonal changes in response to changes in cortical excitability 
(46).  Further research is also warranted in the area of treatment protocol.  Valle et al. showed that 5 
sessions of tDCS per day showed decreases in pain perception for two weeks, while 10 sessions a day 
decreased pain for sixty days (53).  Similarly, how would prolonged stimulation at a low intensity affect 
excitability, and with the effect being dependent on both time and intensity, do increases in time or 
intensity cause differing types of excitability (3)?   
Whether it was the type of exercise, the mechanism of fatigue, excitation of surrounding 
structures, or lack of excitation of the autonomic nervous system, the current study did not see any 
changes based on treatment.  All in all, many of the effects of transcranial direct current stimulation as a 
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physiological modality for improving the lives and performance of a broad array of individuals is a new 
































1. Antal A, Polania R, Schmidt-Samoa C, Dechent P, and Paulus W. Transcranial 
direct current stimulation over the primary motor cortex during fMRI. NeuroImage 55: 
590-596, 2011. 
 
2. Ardolino G, Bossi B, Barbieri S, and Priori A. Non-synaptic mechanisms underlie 
the after-effects of cathodal transcutaneous direct current stimulation of the human brain. 
The Journal of physiology 568: 653-663, 2005. 
 
3. Bastani A, and Jaberzadeh S. Does anodal transcranial direct current stimulation 
enhance excitability of the motor cortex and motor function in healthy individuals and 
subjects with stroke: a systematic review and meta-analysis. Clinical neurophysiology : 
official journal of the International Federation of Clinical Neurophysiology 123: 644-657, 
2012. 
 
4. Been G, Ngo TT, Miller SM, and Fitzgerald PB. The use of tDCS and CVS as 
methods of non-invasive brain stimulation. Brain research reviews 56: 346-361, 2007. 
 
5. Bergmann TO, Groppa S, Seeger M, Molle M, Marshall L, and Siebner HR. Acute 
changes in motor cortical excitability during slow oscillatory and constant anodal 
transcranial direct current stimulation. Journal of neurophysiology 102: 2303-2311, 2009. 
 
6. Boggio PS, Zaghi S, and Fregni F. Modulation of emotions associated with images 
of human pain using anodal transcranial direct current stimulation (tDCS). 
Neuropsychologia 47: 212-217, 2009. 
 
7. Boggio PS, Zaghi S, Lopes M, and Fregni F. Modulatory effects of anodal 
transcranial direct current stimulation on perception and pain thresholds in healthy 
volunteers. European journal of neurology : the official journal of the European Federation of 
Neurological Societies 15: 1124-1130, 2008. 
 
8. Boros K, Poreisz C, Munchau A, Paulus W, and Nitsche MA. Premotor 
transcranial direct current stimulation (tDCS) affects primary motor excitability in humans. 
The European journal of neuroscience 27: 1292-1300, 2008. 
 
9. Brunoni AR, Nitsche MA, Bolognini N, Bikson M, Wagner T, Merabet L, Edwards 
DJ, Valero-Cabre A, Rotenberg A, Pascual-Leone A, Ferrucci R, Priori A, Boggio PS, and 
Fregni F. Clinical research with transcranial direct current stimulation (tDCS): challenges 
and future directions. Brain stimulation 5: 175-195, 2012. 
 




11. Clark VP, Coffman BA, Trumbo MC, and Gasparovic C. Transcranial direct current 
stimulation (tDCS) produces localized and specific alterations in neurochemistry: a (1)H 
magnetic resonance spectroscopy study. Neuroscience letters 500: 67-71, 2011. 
 
12. Cogiamanian F, Brunoni AR, Boggio PS, Fregni F, Ciocca M, and Priori A. Non-
invasive brain stimulation for the management of arterial hypertension. Medical hypotheses 
74: 332-336, 2010. 
 
13. Cogiamanian F, Marceglia S, Ardolino G, Barbieri S, and Priori A. Improved 
isometric force endurance after transcranial direct current stimulation over the human 
motor cortical areas. The European journal of neuroscience 26: 242-249, 2007. 
 
14. Cooper MA, Herda TJ, Vardiman JP, Gallagher PM, and Fry AC. Relationships 
between skinfold thickness and electromyographic and mechanomyographic amplitude 
recorded during voluntary and non-voluntary muscle actions. J Electromyogr Kinesiol 24: 
207-213, 2014. 
 
15. Cooper MA, Herda TJ, Vardiman JP, Gallagher PM, and Fry AC. Relationships 
between the mechanomyographic amplitude patterns of response and concentric isokinetic 
fatiguing tasks of the leg extensors. Physiological measurement 34: 1293-1301, 2013. 
 
16. Enoka RMS, Douglas G. Neurobiology of Muscle Fatigue. Journal of Applied 
Physiology 72: 1631-1648, 1992. 
 
17. Fregni F, Gimenes R, Valle AC, Ferreira MJ, Rocha RR, Natalle L, Bravo R, 
Rigonatti SP, Freedman SD, Nitsche MA, Pascual-Leone A, and Boggio PS. A 
randomized, sham-controlled, proof of principle study of transcranial direct current 
stimulation for the treatment of pain in fibromyalgia. Arthritis and rheumatism 54: 3988-
3998, 2006. 
 
18. Fuglevand AJ, Zackowski KM, Huey KA, and Enoka RM. Impairment of 
neuromuscular propagation during human fatiguing contractions at submaximal forces. 
The Journal of physiology 460: 549-572, 1993. 
 
19. Gandevia SC. Spinal and supraspinal factors in human muscle fatigue. Physiological 
reviews 81: 1725-1789, 2001. 
 
20. Goodall S, Gonzalez-Alonso J, Ali L, Ross EZ, and Romer LM. Supraspinal fatigue 
after normoxic and hypoxic exercise in humans. The Journal of physiology 590: 2767-2782, 
2012. 
 
21. Hansen N. Action mechanisms of transcranial direct current stimulation in 
Alzheimer's disease and memory loss. Frontiers in psychiatry 3: 48, 2012. 
 
22. Ikonomidou C, Qin Qin Y, Labruyere J, and Olney JW. Motor neuron degeneration 
induced by excitotoxin agonists has features in common with those seen in the SOD-1 
29 
 
transgenic mouse model of amyotrophic lateral sclerosis. Journal of neuropathology and 
experimental neurology 55: 211-224, 1996. 
 
23. Knotkova H, Nitsche MA, and Cruciani RA. Putative physiological mechanisms 
underlying tDCS analgesic effects. Frontiers in human neuroscience 7: 628, 2013. 
 
24. Lang N, Siebner HR, Ward NS, Lee L, Nitsche MA, Paulus W, Rothwell JC, Lemon 
RN, and Frackowiak RS. How does transcranial DC stimulation of the primary motor 
cortex alter regional neuronal activity in the human brain? The European journal of 
neuroscience 22: 495-504, 2005. 
 
25. Lepers R, Millet GY, and Maffiuletti NA. Effect of Cycling Cadence on Contractile 
and Neural Properties of Knee Extensors. Medicine and Science in Sport and Exercise 33: 
1882-1888, 2001. 
 
26. Liebetanz D, Nitsche MA, Tergau F, and Paulus W. Pharmacological approach to 
the mechanisms of transcranial DC-stimulation-induced after-effects of human motor 
cortex excitability. Brain : a journal of neurology 125: 2238-2247, 2002. 
 
27. Millet GY, Bachasson D, Temesi J, Wuyam B, Feasson L, Verges S, and Levy P. 
Potential interests and limits of magnetic and electrical stimulation techniques to assess 
neuromuscular fatigue. Neuromuscular disorders : NMD 22 Suppl 3: S181-186, 2012. 
 
28. Miranda PC, Lomarev M, and Hallett M. Modeling the current distribution during 
transcranial direct current stimulation. Clinical neurophysiology : official journal of the 
International Federation of Clinical Neurophysiology 117: 1623-1629, 2006. 
 
29. Miyaguchi S, Onishi H, Kojima S, Sugawara K, Tsubaki A, Kirimoto H, Tamaki H, 
and Yamamoto N. Corticomotor excitability induced by anodal transcranial direct current 
stimulation with and without non-exhaustive movement. Brain research 1529: 83-91, 2013. 
 
30. Molaee-Ardekani B, Marquez-Ruiz J, Merlet I, Leal-Campanario R, Gruart A, 
Sanchez-Campusano R, Birot G, Ruffini G, Delgado-Garcia JM, and Wendling F. Effects 
of transcranial Direct Current Stimulation (tDCS) on cortical activity: a computational 
modeling study. Brain stimulation 6: 25-39, 2013. 
 
31. Montenegro RA, Farinatti Pde T, Fontes EB, Soares PP, Cunha FA, Gurgel JL, 
Porto F, Cyrino ES, and Okano AH. Transcranial direct current stimulation influences the 
cardiac autonomic nervous control. Neuroscience letters 497: 32-36, 2011. 
 
32. Mordillo-Mateos L, Turpin-Fenoll L, Millan-Pascual J, Nunez-Perez N, Panyavin 
I, Gomez-Arguelles JM, Botia-Paniagua E, Foffani G, Lang N, and Oliviero A. Effects of 
simultaneous bilateral tDCS of the human motor cortex. Brain stimulation 5: 214-222, 2012. 
 
33. Newcomer JW, Farber NB, and Olney JW. NMDA receptor function, memory, and 
brain aging. Dialogues in clinical neuroscience 2: 219-232, 2000. 
30 
 
34. Nieuwenhuys R. The insular cortex: a review. Progress in brain research 195: 123-
163, 2012. 
 
35. Nitsche M, and Paulus W. Excitability Changes Induced in the Human Motor Cortex 
by Weak tDCS. Journal Of Physiology 527: 633-639, 2000. 
 
36. Nitsche M, and Paulus W. Sustained Excitability Elevations Induced by tDC Motor 
Cortex Stim in Humans. Neurology 57: 1899-1901, 2001. 
 
37. Nitsche MA, Fricke K, Henschke U, Schlitterlau A, Liebetanz D, Lang N, Henning 
S, Tergau F, and Paulus W. Pharmacological modulation of cortical excitability shifts 
induced by transcranial direct current stimulation in humans. The Journal of physiology 
553: 293-301, 2003. 
 
38. Nitsche MA, Seeber A, Frommann K, Klein CC, Rochford C, Nitsche MS, Fricke K, 
Liebetanz D, Lang N, Antal A, Paulus W, and Tergau F. Modulating parameters of 
excitability during and after transcranial direct current stimulation of the human motor 
cortex. The Journal of physiology 568: 291-303, 2005. 
 
39. Noakes TD, and St Clair Gibson A. Logical Limitations to the Catastrophe Models of 
Fatigue During Exercise in Humans. British journal of sports medicine 38: 648-649, 2004. 
 
40. Noakes TD, St Clair Gibson A, and Lambert EV. From catastrophe to complexity: a 
novel model of integrative central neural regulation of effort and fatigue during exercise in 
humans. British journal of sports medicine 38: 511-514, 2004. 
 
41. Noakes TD, St Clair Gibson A, and Lambert EV. From catastrophe to complexity: a 
novel model of integrative central neural regulation of effort and fatigue during exercise in 
humans: summary and conclusions. British journal of sports medicine 39: 120-124, 2005. 
 
42. Okano AH, Fontes EB, Montenegro RA, Farinatti PD, Cyrino ES, Li LM, Bikson M, 
and Noakes TD. Brain stimulation modulates the autonomic nervous system, rating of 
perceived exertion and performance during maximal exercise. British journal of sports 
medicine 2013. 
 
43. Olney JW. Excitotoxic amino acids and neuropsychiatric disorders. Annual review of 
pharmacology and toxicology 30: 47-71, 1990. 
 
44. Polania R, Nitsche MA, and Paulus W. Modulating functional connectivity patterns 
and topological functional organization of the human brain with transcranial direct current 
stimulation. Human brain mapping 32: 1236-1249, 2011. 
 
45. Poreisz C, Boros K, Antal A, and Paulus W. Safety aspects of transcranial direct 




46. Raimundo RJ, Uribe CE, and Brasil-Neto JP. Lack of clinically detectable acute 
changes on autonomic or thermoregulatory functions in healthy subjects after transcranial 
direct current stimulation (tDCS). Brain stimulation 5: 196-200, 2012. 
 
47. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, and Kuncl RW. Selective loss 
of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Annals of neurology 
38: 73-84, 1995. 
 
48. Ryan ED, Thompson BJ, Herda TJ, Sobolewski EJ, Costa PB, Walter AA, and 
Cramer JT. The relationship between passive stiffness and evoked twitch properties: the 
influence of muscle CSA normalization. Physiological measurement 32: 677-686, 2011. 
 
49. Stagg CJ, and Nitsche MA. Physiological basis of transcranial direct current 
stimulation. The Neuroscientist : a review journal bringing neurobiology, neurology and 
psychiatry 17: 37-53, 2011. 
 
50. Tang CM, Dichter M, and Morad M. Modulation of the N-methyl-D-aspartate 
channel by extracellular H+. Proceedings of the National Academy of Sciences of the United 
States of America 87: 6445-6449, 1990. 
 
51. Taylor JL, E. BJ, M. AG, and Gandevia SC. Changes in Motor Cortical Excitibility 
During Human Muscle Fatigue. Journal Of Physiology 490: 519-528, 1996. 
 
52. Thorstensson A, and Karlsson J. Fatiguability and Fibre Composition of Human 
Skeletal Muscle. Acta Physiologica Scandinavica 98: 318-322, 1976. 
 
53. Valle A, Roizenblatt S, Botte S, Zaghi S, Riberto M, Tufik S, Boggio PS, and 
Fregni F. Efficacy of anodal transcranial direct current stimulation (tDCS) for the treatment 
of fibromyalgia: results of a randomized, sham-controlled longitudinal clinical trial. Journal 
of pain management 2: 353-361, 2009. 
 
54. Weir JP, Beck TW, Cramer JT, and Housh TJ. Is fatigue all in your head? A critical 
review of the central governor model. British journal of sports medicine 40: 573-586; 
discussion 586, 2006. 
 
55. Williams JA, Imamura M, and Fregni F. Updates on the use of non-invasive brain 
stimulation in physical and rehabilitation medicine. Journal of rehabilitation medicine : 
official journal of the UEMS European Board of Physical and Rehabilitation Medicine 41: 305-
311, 2009. 
 
56. Williams PS, Hoffman RL, and Clark BC. Preliminary evidence that anodal 
transcranial direct current stimulation enhances time to task failure of a sustained 
submaximal contraction. PloS one 8: e81418, 2013. 
 
57. Zaghi S, Acar M, Hultgren B, Boggio PS, and Fregni F. Noninvasive brain 
stimulation with low-intensity electrical currents: putative mechanisms of action for direct 
32 
 
and alternating current stimulation. The Neuroscientist : a review journal bringing 
neurobiology, neurology and psychiatry 16: 285-307, 2010. 
 
58. Zheng X, Alsop DC, and Schlaug G. Effects of transcranial direct current 































Figure 1:  
A) EKG measured Heart Rate Variability High Frequency Power of each individual with mean in 
bold. 
B) EKG measured Heart Rate Variability Low Frequency Power of each individual with mean in 
bold. 
C) EKG measured Heart Rate Variability RMSSD of each individual with mean in bold. 
D) EKG measured Heart Rate Variability Variance of each individual with mean in bold. 
E) EKG measured Heart Rate Variability Interbeat Interval of each individual with mean in bold. 
F) EKG measured Heart Rate Variability SD-1 of each individual with mean in bold. 
Figure 2:  
A) EMG measured Evoked Twitch Peak-Peak M-Wave Amplitude change during sham visit of 
each individual with mean in bold. 
B) EMG measured Evoked Twitch Peak-Peak M-Wave Amplitude change during parasympathetic 
visit of each individual with mean in bold. 
C) EMG measured Evoked Twitch Peak-Peak M-Wave Amplitude change during sympathetic visit 
of each individual with mean in bold. 
D) Force Transducer measured Evoked Twitch Torque change during sham visit of each 
individual with mean in bold. 
E) Force Transducer measured Evoked Twitch Torque change during parasympathetic visit of 
each individual with mean in bold. 
F) Force Transducer measured Evoked Twitch Torque change during sympathetic visit of each 
individual with mean in bold. 
Figure 3:  
A) Force Transducer measured Maximum Voluntary Contraction Torque change during 
sympathetic visit of each individual with mean in bold. 
B) Force Transducer measured Maximum Voluntary Contraction Torque change during 
sympathetic visit of each individual with mean in bold. 
C) Force Transducer measured Maximum Voluntary Contraction Torque change during 





Figure 4:  
A) EMG measured Maximum Voluntary Contraction Median Power Frequency change during 
sham visit of each individual with mean in bold. 
B) EMG measured Maximum Voluntary Contraction Median Power Frequency change during 
parasympathetic visit of each individual with mean in bold. 
C) EMG measured Maximum Voluntary Contraction Median Power Frequency change during 
sympathetic visit of each individual with mean in bold. 
Figure 5:  
A) EMG measured Maximum Voluntary Contraction Root Mean Square change during sham visit 
of each individual with mean in bold. 
B) EMG measured Maximum Voluntary Contraction Root Mean Square change during 
parasympathetic visit of each individual with mean in bold. 
C) EMG measured Maximum Voluntary Contraction Root Mean Square change during 
sympathetic visit of each individual with mean in bold. 
 
Figure 6:  
A) Force Transducer measured Mean Torque during Thorstensson Fatigue Protocol of each 
individual with mean in bold. 
B) Force Transducer measured Peak Torque during Thorstensson Fatigue Protocol of each 
individual with mean in bold. 
C) Force Transducer measured Power during Thorstensson Fatigue Protocol of each individual 
with mean in bold. 
Figure 7:  
A) Calculated Torque Fatigue Index during Thorstensson Fatigue Protocol of each individual with 
mean in bold. 
B) Calculated Power Fatigue Index during Thorstensson Fatigue Protocol of each individual with 
mean in bold. 
Figure 8:  
A) EMG Amplitude Slope calculated for the Vastus Lateralus during the Thorstensson Fatigue 
Protocol of each individual with mean in bold. 
B) EMG Amplitude Intercept calculated for the Vastus Lateralus during the Thorstensson Fatigue 
Protocol of each individual with mean in bold. 
C) EMG Amplitude Slope calculated for the Rectus Femoris during the Thorstensson Fatigue 
Protocol of each individual with mean in bold. 
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D) EMG Amplitude Intercept calculated for the Rectus Femoris during the Thorstensson Fatigue 
Protocol of each individual with mean in bold. 
E) EMG Amplitude Slope calculated for the Vastus Medialis during the Thorstensson Fatigue 
Protocol of each individual with mean in bold. 
F) EMG Amplitude Intercept calculated for the Vastus Medialis during the Thorstensson Fatigue 
Protocol of each individual with mean in bold. 
 
Tables: 
Table 1: Descriptive statistics for all Heart Rate Variability measures, broken down by condition. 
Table 2: Descriptive statistics for all Evoked Twitch measures, broken down by condition. 
Table 3: Descriptive statistics for all Maximum Voluntary Contraction measures, broken down by 
condition. 

















































































































































































































































































































































 N Sham 
(mean ± SD) 
Parasympathetic 
(mean ± SD) 
Sympathetic 
(mean ± SD) 
HF (msec2/Hz) 20 7.51 ± 1.08 7.36 ± 1.22 7.21 ± 0.93 
LF (msec2/Hz) 20 8.11 ± 0.79 8.09 ± 0.81 7.92 ± 0.68 
IBI (msec) 20 866.86 ± 138.20 859.45 ± 128.06 847.09 ± 138.25 
RMSSD (msec) 20 59.88 ± 32.18 57.64 ± 31.12 49.33 ± 22.82 
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 N Sham 
(mean ± SD) 
Parasympathetic 
(mean ± SD) 
Sympathetic 
(mean ± SD) 
Power (W) 20 39.90 ± 11.75 39.90 ± 11.68 39.88 ± 11.49 
Mean Torque (Nm) 20 176.98 ± 48.56 174.85 ± 51.76 177.52 ± 52.44 
Peak Torque (Nm) 20 276.57 ± 91.32 277.18 ± 93.30 280.95 ± 91.04 
Torque Fatigue Index (%) 20 61.38 ± 21.63 62.61 ± 21.96 62.26 ± 19.63 
Power Fatigue Index (%) 20 48.48 ± 8.49 49.48 ± 8.64 50.21 ± 8.06 
EMG Amp Slope VL (uV) 20 -0.49 ± 1.01 -0.15 ± 0.89 -0.25 ± 0.89 
EMG Amp Intercept VL (uV) 20 165.31 ± 104.48 157.82 ± 90.97 173.54 ± 102.40 
EMG Amp Slope RF (uV) 20 -0.14 ± 1.03 -0.09 ± 0.95 -0.02 ± 1.05 
EMG Amp Intercept RF (uV) 20 182.69 ± 93.24 185.95 ± 94.53 189.00 ± 105.13 
EMG Amp Slope VM (uV) 20 0.04 ± 1.41 0.15 ± 1.94 0.27 ± 1.89 






















Effects of Transcranial Direct Current Stimulation on Knee 





You are invited to participate in a research study examining the skeletal muscle fatiguing response 
to a brain stimulation technique that is commonly used to treat psychiatric disorders. This study 
will be conducted at the University of Kansas, and 20 subjects (10 males & 10 females) are being 
sought to participate. The Department of Health, Sports, and Exercise Sciences at the University 
of Kansas supports the practice of protection for human subjects participating in research.  The 
following information is provided to help you make an informed decision on whether or not to 
participate in the present study. Please feel free to ask any questions. 
 
PURPOSE OF THE STUDY 
The purpose of this project is to determine the  effect of Transcranial Direct Current Stimulation 
(tDCS) of the brain on muscle fatigue.  Also of interest is the effect of tDCS  on the nervous 
system’s regulation of the heart.  
  
BASIS FOR SUBJECT SELECTION 
You are eligible to participate in this study if you meet certain criteria.  This criteria 
includes being recreationally active, between the ages of 18-30, healthy, non-obese 
(body mass index<28 kg/m2), non-smoking, and free of metabolic or cardiovascular 
diseases. All subjects will be screened using a health-history questionnaire for 
contraindications to exercise by American College of Sports Medicine (ACSM) 
guidelines. Other exclusion criteria include a history of epilepsy or seizures, unhealed 





osteomyelitis (acute or chronic bone infection), myositis ossificans (hardened scarring in 
muscle tissue of the thigh), or past surgery on the right knee. 
 
PROCEDURES 
A time-line of the testing procedures and an overview of the testing sequence for the pre-testing 
and test days are presented below. A more detailed description of these procedures can be found 
immediately after the timeline below. All procedures will be conducted in the Applied Physiology 
Laboratory and the Neuromechanics Laboratory at the University of Kansas and will be 
supervised by trained personnel  
 
Timeline of Testing Procedures 
 
Day 1: (0 hr) (procedures will take approximately 90 minutes) 
 Equipment Familiarization 
Consent Form  
Health History 
Anthropometric Data  
 Electrode Site Preparation 
 Transcranial Stimulation & Heart Rate Variability 
 Evoked Twitches 
 Maximum Voluntary Contractions (MVC’s) 
 Thorstensson Fatiguing Protocol 
 Evoked Twitches 
 MVC’s 
  
Day 2 (> 4 days) (procedures will take approximately 60 minutes) 
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 Electrode Site Preparation 
 Transcranial Stimulation & Heart Rate Variability 
 Evoked Twitches 
 MVC’s 
 Thorstensson Fatiguing Protocol 
 Evoked Twitches 
 MVC’s 
  
Day 3 (> 8 days) (procedures will take approximately 60 minutes) 
 Electrode Site Preparation 
 Transcranial Stimulation & Heart Rate Variability 
 Evoked Twitches 
 MVC’s 
 Thorstensson Fatiguing Protocol 




1) Electrode Site Preparation - You will be asked to sit while each of the six electrode sites 
is cleaned.  This process will include shaving the hair from the area, using tape to remove 
any lotion, sweat, dead skin, or foreign matter, and then cleaning with alcohol.  The reason 
for this is to prevent excess electrical noise that would interfere with the signal from the 
electrode. 
 
2) Transcranial Stimulation – There will be two electrodes placed on the skull, one on either 
the right or left side, just above the ear, with the other being placed on the opposite side 
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forehead, near the hairline.  These electrodes will be damp so that no hair removal is 
necessary, however isopropyl alcohol will be used to clean the hair and scalp below the 
electrodes, ensuring that hair products, sweat, etc. do not impede the electrodes.  Once 
properly connected, the device will be turned on and the parameters will be set to send a 
small amount of electricity (≤ 2.0mA) through your brain.  There could be a slight “tickling” 
sensation, but no discomfort.  Stimulation will be given for 30 minutes under immediate 
supervision of members of the research team.  This will occur on all three visits, however 
each visit will vary.  For one visit the electrode will be on the right side of the scalp, for one 
visit the electrode will be on the left side of the scalp, and for one visit they will be randomly 
placed, and no current will be passed through the electrode after 30 seconds, this visit will 
be known as the “Sham.”  These three visits will be conducted in randomized order. 
 
3) Heart Rate Variability - You will have three electrodes connected to your torso, positioned 
on the uppermost visible vertebrae, right chest, and left abdomen.  This will allow your 
heart rate to be taken, as a means of gathering information on how tDCS affects the 
autonomic nervous system.  You will not feel anything from these electrodes, as they will 
simply be gathering information.  The electrodes will be removed as soon as the tDCS is 
finished.  This will occur on all three visits. 
 
4) Evoked Twitch – Once seated, the researcher will find the pulse in the crease of your hip.  
This will be found just below the waistband of the shorts on the right side.  Digitimer 
electrode will be placed straddling the area where the pulse can be taken, as that is also 
the area where the femoral nerve, one of the main nerves in the leg, resides.  A brief (< 
.05s) low dose electrical current will be sent through the nerve causing the contraction of 
the quadriceps muscles.  A very low dose will be administered at first to assure that you 
understand how it will feel.  From there, increasing doses will be given in 5 mA increments 
until you have reached the maximum force of contraction.  At that point three more doses 
will be administered at a current just above that which produced the maximal contraction.  
The three twitches following fatigue will be given at this same dose. 
 
5) Maximum Voluntary Contraction – You will be seated on the dynamometer (a chair with 
an attached lever arm that will read the forces placed against it as you kick), and safely 
harnessed into the chair.  Electrodes will be connected to the right leg, to read the signal 
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as the tests are performed.  First, you will push against a stationary lever arm for ~3 
seconds to determine the maximum force level.  This will be repeated three times 
immediately prior to the fatiguing protocol and three times immediately following the 
fatiguing protocol.  Following each maximal contraction there will be a two minute rest, 
assuring ample time for the subject to recover, allowing for full effort to be given on every 
MVC.  This will occur on all three visits. 
 
6) Thorstensson Fatiguing Protocol (TFP) - The TFP is a test that measures fatigue over 
over the course of fifty kicks conducted at a constant velocity of 180° per second.  You will 
be seated in the chair attached to the dynamometer so that the lever arm may be moved 
as the knee goes through a range of motion from flexed to extended.   You will be given 
five warm-up knee extensions to ensure that the leg extensors are amply prepared to be 
fatigued.  After the fifth warm-up, the test will begin and you will move the knee from flexed 
to extended fifty times at a constant speed.  Following this you will complete the final 3 




1) Electrode Site Preparation – Some slight scuffs or abrasion of the skin or some slight 
razor burn are the only risks involved with the preparation of the electrode sights.  
 
2) Transcranial Stimulation – The transcranial direct current stimulator is  a device that has 
been used in numerous studies to  affect a broad array of physiological, movement and 
psychological variables.The device sends a small (~ 2 milliamps) electrical current into the 
brain.  
 
This device is not to be used if you have metal implants in the head (excluding standard 





Transcranial Direct Current Stimulation is a safe technique, but there are some small risks 
and possible adverse effects which are described below: 
 
• Slight skin irritation under the electrodes – The skin beneath the electrodes 
may be somewhat red for a short period of time.   There will be not abrasions 
or breaking of the skin, just a slight increase in blood flow causing a red 
appearance. 
• Tingling sensation under the electrodes – This is the most common side 
effect of transcranial direct current stimulation.  It has been described as a 
slight sensation and has occurred in a majority of patients during 
stimulation, but only a few cases linger after stimulation has ceased.  In the 
cases where the sensation did linger, it seems to progressively decrease 
until the sensation is no longer present, normally disappearing in less than 
one hour.  Other feelings that may accompany stimulation are an itching 
feeling at either or both electrode sights, almost solely during stimulation or 
lasting a short time after, mild pain during stimulation with no lingering 
effects after cessation, or a slight burning sensation during stimulation with 
no lasting effects after the finish of stimulation have also been reported. 
• Fatigue during stimulation – In some cases, subjects have suffered a mild 
to moderate feeling of fatigue.  This is feeling of mental fatigue is most 
commonly associated with the stimulation itself, but in a few cases it lasted 
for a couple of hours after the stimulation. 
• Mild headache following stimulation – In very rare cases a headache may 
occur during the stimulation.  Somewhat more often, headaches may occur 
following stimulation, within an hour or so, and can be treated with over the 
counter pain killers. 
• Seizure – There have been no reported incidences of seizure.  However, 
due to the tDCS potential to excite the brain, short lasting, localized seizures 
could be a side effect.  If this were the case, although it could be related to 
grand mal seizures, these incidences would be more similar to fainting or 
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swooning from anxiety. For this reason, it is asked that if you have any 
history of epilepsy, please let the research team know at this time. 
• Mood changes – In rare cases some low level nervousness or 
overexcitement can occur during stimulation.  This has not been reported 
to continue following the stimulation. 
• Nausea – Some feelings of nausea have been reported in rare cases 
following stimulation.  These feelings have been show to last no longer than 
2 hours. 
 
A low number of subjects claimed that transcranial direct current stimulation was 
unpleasant, but most could not tell if the stimulation device was turned on.  There were no 
cases with healthy subjects in which it was requested that the stimulation be terminated. 
 
3) Heart Rate Variability – There are no risks involved, as the electrodes are attached to 
simply read the heart rate. 
 
4) Evoked Twitch – This device has been approved for human subject testing by the FDA, 
and the only risk involved would be the possibility of a slight pinching feeling at the site of 
the twitch. 
 
5) MVC – The only risk involved with the Maximum Voluntary Contractions would be some 
minimal local fatigue lasting a couple of minutes.  Time is given between each MVC to 
allow this fatigue to disappear. As with all exercise, there may be unpleasant sensations 
associated with the muscle contractions, and there will elevations in heart rate, blood 
pressure, and breathing rate. While unlikely, you may also experience an injury of the 
muscles or joints.  
 
6) Thorstensson Fatiguing Protocol – The only risks associated with the Thorstensson 
Fatiguing Protocol are some local fatigue that may last a couple of hours and the possibility 
of some minor local muscle soreness in the right leg for up to one day. As with all exercise, 
there may be unpleasant sensations associated with the muscle contractions, and there 
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will elevations in heart rate, blood pressure, and breathing rate. While unlikely, you may 





We cannot promise any direct benefits to you or others from your taking part in this 
research. However, possible benefits include an improved understanding of how the 
nervous system interacts with skeletal muscle function and how the central nervous 
system has an effect on muscle fatigue. 
 
PAYMENT TO SUBJECTS 
You will not receive any monetary compensation for participating in this study. 
 
COMPENSATION FOR INJURY 
The following information is provided in accordance with HEW regulations: “In the event of injury, 
the Kansas Tort Claims Act provides for compensation if it can be demonstrated that the injury 
was caused by the negligent or wrongful act or omission of a state employee acting within the 
scope of his/her employment.” 
 
IN CASE OF EMERGENCY CONTACT PROCEDURE 
In the event of a research related injury or adverse reaction, please contact Joseph Weir, Ph.D. 
at 785-864-0784 (office), 515-974-9335 (cell) or Philip Gallagher, Ph.D. at 785-864-0772 (office),  
785-550-6300 (cell), or Jake A. Deckert at  620-285-9991 (cell) 
 
INFORMATION TO BE COLLECTED 
To perform this study, researchers will collect information about you. This information will be 
obtained from the health history and physical activity questionnaires, heart rate variability, and 
neuromuscular evaluations. Your name will not be associated in any way with the information 
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collected about you or with the research findings from this study. The researchers will use a study 
identification number or initials in place of your name. All of your data will be stored on a password 
protected computer or in a locked filing cabinet located in a locked office of the applied physiology 
laboratory. The researchers will not share information about you with anyone outside of the 
Applied Physiology Laboratory personnel unless required by law or unless you give written 
permission. 
 
Permission granted on this date to use and disclose your information remains in effect indefinitely. 
By signing this form you give permission for the use and disclosure of your information for the 
purposes of this study at any time in the future. 
 
REFUSAL TO SIGN CONSENT AND AUTHORIZATION 
You are not required to sign this Consent and Authorization form and you may refuse to do so 
without affecting your right to any services you are receiving or may receive from the University 
of Kansas or to participate in any programs or events of the University of Kansas. However, if you 
refuse to sign, you cannot participate in this study. 
 
CANCELLING THIS CONSENT AND AUTHORIZATION 
You may withdraw your consent to participate in this study at any time. You also have the right to 
cancel your permission to use and disclose information collected about you, in writing, at any 
time, by sending your written request to: Joseph Weir, Ph.D., University of Kansas, 1301 
Sunnyside Avenue, Robinson Center Room 100, Lawrence, Kansas 66045. If you cancel 
permission to use your information, the researchers will stop collecting additional information 
about you. However, the research team may use and disclose information that was gathered 
before they received your cancellation, as described above. 
 
PARTICIPANT CERTIFICATION 
I have read this Consent and Authorization form. I have had the opportunity to ask, and I have 
received answers to, any questions I had regarding the study and the use and disclosure of 
information about me for the study. I understand that if I have any additional questions about this 
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study you may call Jake A. Deckert (620-285-9991) or e-mail: jaked6@ku.edu or Prof Joseph 
Weir (785-864-0784) or e-mail: joseph.weir@ku.edu.  I understand that if I have any additional 
questions about my rights as a research participant, I may call (785) 864-7429 or write the Human 
Subjects Committee Lawrence Campus (HSCL), University of Kansas, 2385 Irving Hill Road, 





I agree to take part in this study titled ‘Effects of Transcranial Direct Current Stimulation on Knee 
Extensors During Thorstensson Fatigue Protocol’ as a research participant. I further agree to the 
uses and disclosures of my information as described above. By my signature I affirm that I am at 
least 18 years old and that I have received a copy of this Consent and Authorization form. 
 
___________________________________    ___________________________________ 





________________________________    ___________________________________ 






_________________________________    ___________________________________ 







RESEARCHER CONTACT INFORMATION 
Joseph P. Weir, PhD     Jake A. Deckert 
Department Chair/Primary Investigator  Secondary Investigator 
Health Sport and Exercise Sciences   Health Sport and Exercise Sciences 
100 Robinson Center     208 Robinson Center 
1301 Sunnyside Avenue    1301 Sunnyside Avenue 
University of Kansas     University of Kansas 
Lawrence, KS 66045     Lawrence, KS 66045 
 
Trent J. Herda, PhD     Philip M. Gallagher, PhD 
Secondary Investigator    Secondary Investigator 
Health Sport and Exercise Sciences   Health Sport and Exercise Sciences 
101 Robinson      101 Robinson 
1301 Sunnyside Avenue    1301 Sunnyside Avenue 
University of Kansas     University of Kansas 












Name ________________________________________________ Date______________ 
 
Home Address __________________________________________________________________ 
 




Person to contact in case of emergency__________________________________________ 
 
Emergency Contact Phone ______________________  
 
Personal Physician ____________________________ Physician’s Phone_______________ 
 
Gender ________ Age ______(yrs) Height ______(ft)______(in)     Weight______(lbs) 
 
Does the above weight indicate:  a gain____   a loss____   no change____   in the past year? 
If a change, how many pounds?___________(lbs) 
 
 
A. JOINT-MUSCLE STATUS (Check areas where you currently have problems) 
 
Joint Areas     Muscle Areas 
(    )  Wrists     (    )  Arms 
(    )  Elbows     (    )  Shoulders 
(    )  Shoulders     (    )  Chest 
PRE-EXERCISE TESTING 




(    )  Upper Spine & Neck   (    )  Upper Back & Neck 
(    )  Lower Spine    (    )  Abdominal Regions 
(    )  Hips     (    )  Lower Back 
(    )  Knees     (    )  Buttocks 
(    )  Ankles     (    )  Thighs 
(    )  Feet     (    )  Lower Leg 
(    )  Other_______________________  (    )  Feet 
      (    )  Other_____________________ 
 
B.   HEALTH STATUS (Check if you currently have any of the following conditions) 
 
(    )  High Blood Pressure   (    )  Acute Infection 
(    )  Heart Disease or Dysfunction  (    )  Diabetes or Blood Sugar Level Abnormality 
(    )  Peripheral Circulatory Disorder  (    )  Anemia 
(    )  Lung Disease or Dysfunction  (    )  Hernias 
(    )  Arthritis or Gout    (    )  Thyroid Dysfunction 
(    )  Edema     (    )  Pancreas Dysfunction 
(    )  Epilepsy     (    )  Liver Dysfunction 
(    )  Multiply Sclerosis    (    )  Kidney Dysfunction 
(    )  High Blood Cholesterol or   (    )  Phenylketonuria (PKU)  
         Triglyceride Levels   (    )  Loss of Consciousness    
(    )  Allergic reactions to rubbing alcohol  
 
 Have you, or anyone in your family, ever been diagnosed with bipolar or other psychiatric 





NOTE: If any of these conditions are checked, then a physician’s health clearance will required.  




C.  IMPLANTED DEVICES 
Do you currently have any implanted devices that emit an electrical signal (pacemakers, cochlea 
implants, etc.) 
 YES_________ NO_________ 
 
Do you have any metal implants in above the neck (excluding standard orthodontic braces, 
fillings, etc.) 
 YES_________ NO_________ 
  
D. PHYSICAL EXAMINATION HISTORY 
 Approximate date of your last physical examination______________________________ 
  
 Physical problems noted at that time__________________________________________ 
 
 Has a physician ever made any recommendations relative to limiting your level of  physical 
exertion? _________YES __________NO 
 If YES, what limitations were recommended?___________________________________ 
 ________________________________________________________________________ 
 
E.   CURRENT MEDICATION USAGE  
(List the drug name, the condition being managed, and the length of time used) 
 
         MEDICATION          CONDITION            LENGTH OF USAGE 
_____________________ ______________________________ _________________ 
_____________________ ______________________________ _________________ 
 
F.   PHYSICAL PERCEPTIONS  
(Indicate any unusual sensations or perceptions.  Check if you have recently experienced any of the 
following during or soon after physical activity (PA); or during sedentary periods (SED)) 
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PA SED      PA SED 
(    ) (    )  Chest Pain     (    ) (    )  Nausea 
(    ) (    )  Heart Palpitations    (    ) (    )  Light Headedness 
(    ) (    )  Unusually Rapid Breathing  (    ) (    )  Loss of Consciousness 
(    ) (    )  Overheating    (    ) (    )  Loss of Balance 
(    ) (    )  Muscle Cramping    (    ) (    )  Loss of Coordination 
(    ) (    )  Muscle Pain    (    ) (    )  Extreme Weakness 
(    ) (    )  Joint Pain     (    ) (    )  Numbness 




G. FAMILY HISTORY  
(Check if any of your blood relatives . . . parents, brothers, sisters, aunts, uncles, and/or grandparents . 
. . have or had any of the following) 
 (    )  Heart Disease 
 (    )  Heart Attacks or Strokes (prior to age 50) 
 (    )  Elevated Blood Cholesterol or Triglyceride Levels 
 (    )  High Blood Pressure 
 (    )  Diabetes 
 (    )  Sudden Death (other than accidental) 
 
 Have you, or anyone in your family, ever been diagnosed with bipolar or other psychiatric 






H.   EXERCISE STATUS 
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Do you regularly engage in aerobic forms of exercise (i.e., jogging, cycling, walking, etc.)?    
YES__________        NO_________ 
How long have you engaged in this form of exercise?  ______ years ______ months 
How many hours per week do you spend for this type of exercise?  _______ hours 
 
Do you regularly lift weights?           
YES_________        NO_________ 
How long have you engaged in this form of exercise?  ______ years ______ months 
How many hours per week do you spend for this type of exercise?  _______ hours 
 
Do you regularly play recreational sports (i.e., basketball, racquetball, volleyball, etc.)?    
YES_________        NO_________ 
How long have you engaged in this form of exercise?  ______ years ______ months 
How many hours per week do you spend for this type of exercise?  _______ hours 
 
 
